221 related articles for article (PubMed ID: 28467792)
1. Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.
Sakka L; Delétage N; Chalus M; Aissouni Y; Sylvain-Vidal V; Gobron S; Coll G
Oncotarget; 2017 Jun; 8(26):42789-42807. PubMed ID: 28467792
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
3. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
4. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
[TBL] [Abstract][Full Text] [Related]
5. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
6. Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.
Schilström B; Konradsson-Geuken A; Ivanov V; Gertow J; Feltmann K; Marcus MM; Jardemark K; Svensson TH
Synapse; 2011 May; 65(5):357-67. PubMed ID: 20730799
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.
Zhang L; Rasenick MM
J Pharmacol Exp Ther; 2010 Mar; 332(3):977-84. PubMed ID: 19996298
[TBL] [Abstract][Full Text] [Related]
10. R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
Sánchez C; Kreilgaard M
Pharmacol Biochem Behav; 2004 Feb; 77(2):391-8. PubMed ID: 14751469
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
[TBL] [Abstract][Full Text] [Related]
12. R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model.
Sánchez C
Eur J Pharmacol; 2003 Mar; 464(2-3):155-8. PubMed ID: 12620508
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
[TBL] [Abstract][Full Text] [Related]
14. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
Sánchez C; Gruca P; Papp M
Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
[TBL] [Abstract][Full Text] [Related]
15. SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects.
Paul MA; Gray GW; Love RJ; Lange M
Aviat Space Environ Med; 2007 Jul; 78(7):693-7. PubMed ID: 17679567
[TBL] [Abstract][Full Text] [Related]
16. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
[TBL] [Abstract][Full Text] [Related]
17. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.
Schreiber S; Pick CG
Eur Neuropsychopharmacol; 2006 Aug; 16(6):464-8. PubMed ID: 16413173
[TBL] [Abstract][Full Text] [Related]
18.
Gao YL; He B
DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
[TBL] [Abstract][Full Text] [Related]
19. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
[TBL] [Abstract][Full Text] [Related]
20. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
